Cargando…

Prophylactic Antitubercular Therapy Is Associated With Accelerated Disease Progression in Patients With Crohn's Disease Receiving Anti-TNF Therapy: A Retrospective Multicenter Study

Prophylactic antitubercular therapy (ATT) is widely prescribed in patients with Crohn's disease (CD) receiving antitumor necrosis factor (anti-TNF) treatment. However, antitubercular agents have been demonstrated to possess profibrotic effects. We aimed to evaluate whether ATT accelerated disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fen, Tang, Jian, Ye, Lingna, Tan, Jinyu, Qiu, Yun, Hu, Fan, He, Jinshen, Chen, Baili, He, Yao, Zeng, Zhirong, Mao, Ren, Cao, Qian, Gao, Xiang, Chen, Minhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236600/ https://www.ncbi.nlm.nih.gov/pubmed/35758823 http://dx.doi.org/10.14309/ctg.0000000000000493

Ejemplares similares

A nomogram incorporating ileal and anastomotic lesions separately to predict the long-term outcome of Crohn’s disease after ileocolonic resection
por: Xiong, Shanshan, et al.
Publicado: (2023)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
por: Li, Tong, et al.
Publicado: (2020)

Intestinal strictures in Crohn’s disease: a 2021 update
por: Lin, Xiaoxuan, et al.
Publicado: (2022)

Early transmural healing and its predictors assessed by magnetic resonance enterography in patients with Crohn’s disease receiving ustekinumab
por: Zhou, Longyuan, et al.
Publicado: (2023)

Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease
por: Huang, Shanshan, et al.
Publicado: (2019)

Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqin, et al.
Publicado: (2020)

Correction to: Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqing, et al.
Publicado: (2020)

A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021)

Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease
por: Zhao, Yue, et al.
Publicado: (2020)

Anti-TNF Therapy in Crohn’s Disease
por: Adegbola, Samuel O., et al.
Publicado: (2018)

A New Model Based on 25-Hydroxyvitamin D3 for Predicting Active Crohn's Disease in Chinese Patients
por: Lin, Sinan, et al.
Publicado: (2018)

Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease
por: Zhuang, Xiaojun, et al.
Publicado: (2022)

Fibrosis in fat: From other diseases to Crohn’s disease
por: Xiong, Shanshan, et al.
Publicado: (2022)

Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti‐TNF therapy in a tuberculosis endemic region
por: Ye, Lingna, et al.
Publicado: (2020)

Renal Cell Carcinoma in Fistulizing Crohn's Disease Patient Who Received Anti-TNF α Therapy
por: Albishi, Abdullah Mohammed, et al.
Publicado: (2021)

Gut Microbiota Profiles and Microbial-Based Therapies in Post-operative Crohn's Disease: A Systematic Review
por: Zhuang, Xiaojun, et al.
Publicado: (2021)

Pharmacovigilance of Antitubercular Therapy in Tuberculosis
por: Ravichandran, Mirunalini, et al.
Publicado: (2022)

Current diagnosis and management of Crohn’s disease in China: results from a multicenter prospective disease registry
por: Li, Yue, et al.
Publicado: (2019)

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease
por: Chen, Rirong, et al.
Publicado: (2020)

Regulatory T cells in Crohn's disease following anti‐TNF‐α therapy
por: Chiba, Toshimi, et al.
Publicado: (2019)

Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn’s Disease
por: Boronat-Toscano, Albert, et al.
Publicado: (2022)

Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3
por: Li, Manying, et al.
Publicado: (2017)

Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease
por: Wang, Huiling, et al.
Publicado: (2016)

Earlier anti-TNF therapy reduces the risk of malnutrition associated with alterations in body composition in patients with Crohn’s disease
por: Wang, Yuexin, et al.
Publicado: (2023)

A primary hepatic lymphoma in a patient with Crohn's disease receiving thiopurine and anti-TNF therapy: a case report
por: Merhaben, Salma, et al.
Publicado: (2023)

Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
por: Chen, Rirong, et al.
Publicado: (2023)

Disseminated Tuberculosis in a Patient Taking Anti-TNF Therapy for Crohn's Disease
por: Wang, Ming-Hsi, et al.
Publicado: (2015)

Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2021)

Mucosa-Associated Oscillospira sp. Is Related to Intestinal Stricture and Post-Operative Disease Course in Crohn’s Disease
por: Zhan, Shukai, et al.
Publicado: (2023)

Cellular and Molecular Mechanisms of Intestinal Fibrosis
por: Wu, Xiaomin, et al.
Publicado: (2023)

Intestinal Tuberculosis Masquerading as Crohn's Disease? A Case of Disseminated Tuberculosis after Anti-TNF Therapy for Suspected Crohn's Disease
por: Abadir, Alexander P., et al.
Publicado: (2019)

Risk factors and long-term outcome of disease extent progression in Asian patients with ulcerative colitis: a retrospective cohort study
por: Qiu, Yun, et al.
Publicado: (2019)

Thalidomide-induced sinus bradycardia in Crohn’s disease: case report and literature review
por: Liu, Menghui, et al.
Publicado: (2019)

The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn’s disease activity
por: Eder, Piotr, et al.
Publicado: (2015)

Paradoxical SAPHO syndrome observed during anti-TNFα therapy for Crohn’s disease
por: Amano, Hitoshi, et al.
Publicado: (2017)

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
por: Chaparro, María, et al.
Publicado: (2019)

Anti-TNF Therapy Before Intestinal Surgery for Crohn’s Disease and the Risks of Postoperative Complications
por: Soop, Mattias, et al.
Publicado: (2021)

Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease
por: Ye, Chenglin, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn’s disease patients with isolated anastomotic lesions
por: Chen, Rirong, et al.
Publicado: (2023)

Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease
por: Chen, Peng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c3m2nhei7m3qcsdvt6di1v34op